Effectiveness of an Indian-made attenuated influenza A(H1N1)pdm 2009 vaccine: A case control study

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 3, 2014, Pages 566-571

  Kulkarni, Prasad S ^a   Agarkhedkar, Sharad ^b   Lalwani, Sanjay ^c   Bavdekar, Ashish R ^d   Jog, Sameer ^e   Raut, Sidram K ^f   Parulekar, Varsha ^g   Agarkhedkar, Shalaka S ^b   Palkar, Sonali ^c   Mangrule, Somnath ^a  

^a Serum Institute of India Ltd   (India)

^b HOSPITAL AND RESEARCH CENTRE   (India)

^c Bharati Vidyapeeth's Medical College   (India)

^d KEM HOSPITAL   (India)

^e DEENANATH MANGESHKAR HOSPITAL   (India)

^f Nobel Hospital   (India)

^g Diagnosearch Laboratory Services   (India)

Author keywords

Case control; Effectiveness; Influenza A(H1N1)pdm 2009; Live attenuated vaccine; Pandemic

Indexed keywords

SWINE INFLUENZA VACCINE; ZANAMIVIR; INFLUENZA VACCINE; LIVE VACCINE; VIRUS RNA;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HUMAN; INDIA; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; THROAT CULTURE; ADOLESCENT; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INDIA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT OUTCOME; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 84898439463     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.27490     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:467-70; PMID:19444150
2. World Health Organization. Pandemic (H1N1) 2009 - update 69. [Accessed 21 August 2012]. Available from: http://www.who.int/csr/don/2009-10-09/en/index. html.
3. World Health Organization. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html (Accessed June 11, 2009).
4. Ministry of Health and Family Welfare. Government of India: Update of influenza A (H1N1) as on 17th May, 2009. Press release dated 17th May, 2009. [Accessed on 21 August 2012]. Available from: http://pib.nic.in/newsite/ erelease.aspx?relid=48762].
5. Mishra AC, Chadha MS, Choudhary ML, Potdar VA. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS One 2010; 5:e10540; PMID:20479875; http://dx.doi.org/10.1371/journal.pone.0010540
6. Ministry of Health and Family Welfare. Government of India: Situational updates. [Accessed on 15 March 2011]. Available from: http://mohfw-h1n1.nic.in/ documents/PDF/SituationalUpdatesArchives/december2010/ Situational%20Updates%20on%2027.12.2010.pdf.
7. Ministry of Health and Family Welfare. Government of India: Epidemiological trends. [Accessed on 21 August 2012]. Available from: http://mohfw-h1n1.nic.in/Epidemiological.html.
8. Kulkarni PS, Manjunath K, Agarkhedkar S; Group of SII IIV Studies. Safety and immunogenicity of an adjuvanted whole virion, inactivated A (H1N1) 2009 influenza vaccine in young and elderly adults, and children. Vaccine 2012; 31:20-2; PMID:23131207; http://dx.doi.org/10.1016/j.vaccine.2012.10.081
9. Stittelaar KJ, Veldhuis Kroeze EJ, Rudenko L, Dhere R, Thirapakpoomanunt S, Kieny MP, Osterhaus AD. Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets. Vaccine 2011; 29:9265-70; PMID:21945964; http://dx.doi.org/10.1016/j.vaccine.2011.09.049
10. Dhere R, Yeolekar L, Kulkarni P, Menon R, Vaidya V, Ganguly M, Tyagi P, Barde P, Jadhav S. A pandemic influenza vaccine in India: from strain to sale within 12 months. Vaccine 2011; 29(Suppl 1):A16-21; PMID:21684421; http://dx.doi.org/10.1016/j.vaccine.2011.04.119
11. Puig-Barberà J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Pérez-Vilar S, Silvestre-Silvestre E, Calvo-Mas C, Safont-Adsuara L, Ruiz-García M; Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010; 28:7460-7; PMID:20875486; http://dx.doi.org/10.1016/j.vaccine. 2010.09.042
12. Van Buynder PG, Dhaliwal JK, Van Buynder JL, Couturier C, Minville-Leblanc M, Garceau R, Tremblay FW. Protective effect of single-dose adjuvanted pandemic influenza vaccine in children. Influenza Other Respir Viruses 2010; 4:171-8; PMID:20629771; http://dx.doi.org/10.1111/j.1750-2659. 2010.00146.x
13. Skowronski DM, De Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, et al.; Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258; PMID:20386731; http://dx.doi.org/10.1371/journal.pmed. 1000258
14. Savulescu C, Valenciano M, de Mateo S, Larrauri A; cycEVA Study Team. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network - pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine 2010; 28:2903-7; PMID:20153351; http://dx.doi.org/10.1016/j.vaccine.2010.01.054
15. Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, Miller E, Zambon M. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health 2010; 64:1062-7; PMID:19910645; http://dx.doi.org/10.1136/jech.2009.093450
16. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, Foust A, Lindstrom S, Shay DK; Marshfield Influenza Study Group. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67; PMID:19086915; http://dx.doi.org/10.1086/595861
17. Song JY, Cheong HJ, Heo JY, Noh JY, Choi WS, Park DW, Lee J, Jeong HW, Kee SY, Kim WJ. Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. Vaccine 2011; 29:1395-8; PMID:21199701; http://dx.doi.org/10. 1016/j.vaccine.2010.12.050
18. Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill 2011; 16:19763; PMID:21251487
19. Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M. Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. Vaccine 2011; 29:7975-81; PMID:21884747; http://dx.doi.org/10.1016/j.vaccine.2011.08.068
20. Fielding JE, Grant KA, Garcia K, Kelly HA. Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010. Emerg Infect Dis 2011; 17:1181-7; PMID:21762570; http://dx.doi.org/10.3201/eid1707. 101959
21. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx.doi.org/10.1016/ S1473-3099(11)70295-X
22. Puig-Barberà J, Díez-Domingo J, Arnedo-Pena A, Ruiz-García M, Pérez-Vilar S, Micó-Esparza JL, Belenguer-Varea A, Carratalá-Munuera C, Gil-Guillén V, Schwarz-Chavarri H. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012; 30:5714-20; PMID:22819720; http://dx.doi.org/10.1016/j.vaccine.2012.07.006
23. Fielding JE, Grant KA, Papadakis G, Kelly HA. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008. BMC Infect Dis 2011; 11:170; PMID:21669006; http://dx.doi.org/10.1186/1471-2334-11-170
24. Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, Ji W, Suo L, Liu D, Ma R, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010; 363:2416-23; PMID:21158658; http://dx.doi.org/10.1056/NEJMoa1006736
25. CDC protocol of realtime RTPCR for influenza A (H1N1). Geneva: World Health Organization, (2009). [Accessed on 20 July 2009]. Available from: http://www.who.int/csr/resources/publications /swinef lu/CDCRealtimeRTPCR- SwineH1Assay-2009-20090428.pdf